MedPath

Management of Traumatic Bone Defects in Tibial Plateau Fractures With Antibiotic-Impregnated Biodegradable Calcium Sulfate Beads: A Prospective Clinical Trial

Not Applicable
Completed
Conditions
Fracture Fixation, Internal
Tibial Fractures
Intra-Articular Fractures
Interventions
Device: Calcium Sulfate + Antibiotics + Internal Fixation
Registration Number
NCT02456194
Lead Sponsor
Ross Leighton
Brief Summary

This is a prospective clinical trial of tibial plateau fractures treated with internal fixation and a calcium sulfate graft which can be mixed with antibiotics and molded into various bead sizes for implantation into bone defects. The graft material chosen for this study is STIMULAN Rapid Cure (Biocomposites, UK), which is approved for use as a bone void filler and may be mixed with a variety of antibiotics. The combination of STIMULAN + antibiotic in bead form is the "study device".

Our primary study aim is to look at resorption and remodeling of the study device into bone. Another important aim of the study is to look at subsidence, or collapse, of the joint surface.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Adult (skeletally mature) men or women;
  • Acute, closed, tibial plateau fractures, Schatzker grade 1 through 5;
  • Internal fixation and use of study device per protocol;
  • Fracture repair within 30 days of injury;
  • Signed informed consent to participate in study.
Exclusion Criteria
  • Uncontrolled diabetes;
  • Severe degenerative or metabolic bone disease;
  • Malignancy;
  • Severe vascular or neurologic disease;
  • Alcoholism;
  • Substance abuse;
  • Use of systemic steroids;
  • Immunosuppressive therapy;
  • Hypercalcaemia;
  • Renal-compromised patients;
  • Osteomyelitis or chronic infection in the study limb;
  • Women who are pregnant or breast-feeding.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Calcium Sulfate + Antibiotics + Internal FixationCalcium Sulfate + Antibiotics + Internal Fixation-
Primary Outcome Measures
NameTimeMethod
Resorption of Study Device6 months

Number of participants with any study device remaining visible on CT

Secondary Outcome Measures
NameTimeMethod
Knee Injury Osteoarthritis Outcome Score - Quality of Life Subscale12 months

Self-reported outcome score, reported as the mean score at each time point. Scale 0-100, 100 is best.

Resorption of Study Device12 months

Number of participants with any study device remaining visible on x-ray

Knee Injury Osteoarthritis Outcome Score - Pain Subscale12 months

Self-reported outcome score, reported as the mean score at each time point. Scale 0-100, 100 is best.

Range of Motion12 months

Range of knee motion (active flexion) in degrees

Subsidence of Joint Surface6 weeks, 3 months, 6 months, 12 months

Amount of collapse of the joint surface, measured in mm, on plain x-ray. Reported as number of participants with at least 2mm of subsidence on x-ray.

Knee Injury Osteoarthritis Outcome Score - Symptoms Subscale12 months

Self-reported outcome score, reported as the mean score at each time point. Scale 0-100, 100 is best.

Knee Injury Osteoarthritis Outcome Score - Activities of Daily Living Subscale12 months

Self-reported outcome score, reported as the mean score at each time point. Scale 0-100, 100 is best.

Knee Injury Osteoarthritis Outcome Score - Sports/Recreation Subscale12 months

Self-reported outcome score, reported as the mean score at each time point. Scale 0-100, 100 is best.

Trial Locations

Locations (5)

Horizon Health Network

🇨🇦

Moncton, New Brunswick, Canada

Halifax Infirmary

🇨🇦

Halifax, Nova Scotia, Canada

Hopital du Sacre-Coeur de Montreal

🇨🇦

Montreal, Quebec, Canada

Alberta Health Services

🇨🇦

Calgary, Alberta, Canada

Memorial University of Newfoundland

🇨🇦

Saint John's, Newfoundland and Labrador, Canada

© Copyright 2025. All Rights Reserved by MedPath